Company Profile
Sichuan Kelun Pharmaceutical researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and globally. Its operations are structured into Chuanning, Botai, and Business segments. The company offers infusion products.
Its portfolio also includes oral medication and dosage form, medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes, over-the-counter products, and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and indications
Ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. Additionally, it engages in investment.
Its portfolio also includes import and export, enterprise management, logistics and transportation, business services, agricultural non-staple food processing, production and sale of pharmaceutical intermediates, R&D of bio-based materials technology, Internet and related services, crop planting, professional technical, biotechnology extension, socio-economic consultation, technology promotion, medical research and testing exhibition, general cargo road transport, ecological protection and environmental management, and wholesale and retail.
It exports its products to Japan. Founded in 1996 and based in Chengdu, the People's Republic of China, the company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd before rebranding in August 2003. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.